Kahramanmaras Sutcu Imam University   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Kahramanmaraş Turkey (1992)

Organization Overview

First Clinical Trial
2011
NCT01423838
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

KahramanmaraşISU | Kahramanmaras Sutcu Imam University | Kahramanmaraş Sütçü İmam University | Kahramanmaraş Sutcu Imam University Faculty of Medicine Kahramanmaraş | Kahramanmaraş Sütçü İmam University institute of health sciences.

Active Ingredients

Drugs in Phase 4 Trials (3)

levobupivacaine (chirocaine) (1 trial)

oxybutynin (ditropan) (1 trial)

solifenacin (vesicare) (1 trial)

Drugs in Phase 3 Trials (1)

azelastine (astelin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Forearm Injuries (Phase 4)

Hand Injuries (Phase 4)

Urinary Bladder, Overactive (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4